Rocket Lab shares rose as the company announced a multi-year agreement to launch 20 Electron missions for Tokyo-based Earth observation company Synspective. The deal is the largest commercial launch contract in Electron’s history and brings Synspective’s total Rocket Lab missions to 47, the most of any Rocket Lab customer. The missions will carry StriX synthetic aperture radar satellites to sun-synchronous orbit from Launch Complex 1, with launches scheduled annually from 2028 through 2031. Synspective aims to build a constellation capable of imaging any location on Earth within hours, day or night, and in any weather. Rocket Lab said the agreement was the latest in a series of multi-launch contracts this year, taking its launch backlog beyond 100 missions. At the time of publication Friday, Rocket Lab shares were up 6.29% at $74.89, while the Nasdaq rose 0.93%, the S&P 500 gained 0.53% and industrials advanced 0.58%. Technical indicators showed the stock about 9% above its 20-day simple moving average of $67.81 and about 6% above its 50-day average of $69.76, but about 15% below its 100-day average of $87.01 and about 9% below its 200-day average of $81.41. The 20-day average remains below the 50-day average, while the 50-day average remains below the 200-day average, a death cross formed in August. Traders are watching whether the rebound develops into a more durable base after July’s swing low and August’s swing high. Key levels identified were resistance at $75.50 and support at $61.